An investigation for investors in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares over potential securities laws violations by Intercept Pharmaceuticals, Inc. was announced.
This press release was orginally distributed by SBWire
San Diego, CA — (SBWIRE) — 11/03/2020 — Intercept Pharmaceuticals, Inc. is under investigation concerning potential securities laws violations by Intercept Pharmaceuticals, Inc. in connection with certain financial statements.
Investors who purchased shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether a series of statements by Intercept Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
New York based Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. On October 8, 2020, news outlets reported that Intercept Pharmaceuticals, Inc. was “facing an investigation from the U.S. Food and Drug Administration over the potential risk of liver injury in patients taking Ocaliva, [Intercept’s] treatment for primary biliary cholangitis, a rare, chronic liver disease.” Shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) declined from $125.00 per share in late 2019 to as low as $27.83 per share on October 23, 2020.
Those who purchased shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit: http://www.sbwire.com/press-releases/nasdaqicpt-shareholder-notice-investigation-over-possible-securities-laws-violations-by-intercept-pharmaceuticals-inc-1314555.htm